VBI Vaccines

-$0.0131 (-1.57%) As of 11:24 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VBI Vaccines and other ETFs, options, and stocks.

About VBIV

VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601.

CEO
Jeffrey R. Baxter
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
1965

VBIV Key Statistics

Market cap
215.49M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.75M
High today
$0.87
Low today
$0.8157
Open price
$0.8157
Volume
887.60K
52 Week high
$3.81
52 Week low
$0.6405

VBIV Earnings

-$0.08
-$0.05
-$0.03
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure